Stefano Tarantolo, M.D., F.A.C.P.
Expertise: Myeloma & Lymphoma
- Non-Hodgkins Lymphoma
- Hodgkins Lymphoma
- Multiple Myeloma
- Waldenstroms Macroglobulinemia
- Amyloidosis
Previous Director of the Myeloma Program at the University of Nebraska Medical Center, NCCN guidelines member for Myeloma
PROFESSIONAL EDUCATION & TRAINING:
Hematology & Oncology Fellowship: University of Medicine & Dentistry New Jersey - Robert Wood Johnson Medical School
Residencies: Internal Medicine, Jersey Shore Medical Center
Medical School: M.D., St. George's University School of Medicine
Education: B.S., Cook College/Rutgers University, New Brunswick, NJ
BOARD CERTIFICATIONS:
- American Board of Internal Medicine: Internal Medicine
- American Board of Internal Medicine: Medical Oncology
- American Board of Internal Medicine: Hematology
CURRENT POSITIONS:
- Director of Stem Cell Transplant Program Methodist Hospital, Omaha
- President-Elect Nebraska Oncology Association
PREVIOUS POSITIONS & APPOINTMENTS:
- Associate Professor of Medicine, University of Nebraska Medical Center
- Myeloma Program Director, University of Nebraska Medical Center
PROFESSIONAL ACTIVITIES, MEMBERSHIPS & ACCOMPLISHMENTS:
- 2009/2010 Best Doctors in America in Medical Oncology and Hematology
- NCCN guidelines Panel for Myeloma & Melanoma
-
Nebraska Medical Association
-
The American Society of Hematology
-
The American Society of Clinical Oncology
-
The American Society of Blood & Marrow Transplantation
-
The American College of Physicians
-
The International Society for Experimental Hematology
-
International Immunocompromised Host Society
RESEARCH INTERESTS:
Clinical: Multiple Myeloma
- Allogeneic and Autologous Transplantation
- Adoptive Immunotherapy
- Novel Therapies
Laboratory: Multiple Myeloma